Pregabalin open-label add-on trial: An open-label, multicenter follow-on study to determine long-term safety & efficacy in patients with partial seizures

  • Bladin, Christopher (Primary Chief Investigator (PCI))
  • Reutens, David, (Chief Investigator (CI))

Project: Research

StatusNot started